Drug maker AstraZeneca has agreed to pay $520 million to settle federal whistleblower lawsuits that accused the company of engaging in illegal tactics -- including kickbacks to doctors -- to promote "off-label" uses for its anti-psychotic drug Seroquel. The settlement is the largest amount ever paid by a company in a civil-only settlement of off-label marketing claims. The federal government will receive $302 million, and states will share up to $218 million.
Whistleblower Suits Against AstraZeneca Settle for $520 Million
The Legal Intelligencer
April 28, 2010